about
Symptomatic treatments for amyotrophic lateral sclerosis/motor neuron diseaseMultidisciplinary care for adults with amyotrophic lateral sclerosis or motor neuron diseaseMultidisciplinary care for adults with amyotrophic lateral sclerosis or motor neuron diseaseNanostructures for peroxidasesImplications of glial nitric oxide in neurodegenerative diseasesPrenatal exposure to high levels of glucocorticoids increases the susceptibility of cerebellar granule cells to oxidative stress-induced cell deathDiscovery of molecular mechanisms of neuroprotection using cell-based bioassays and oligonucleotide arrays.Proteomic identification of nitrated proteins in Alzheimer's disease brain.Apoptosis in amyotrophic lateral sclerosis: a review of the evidence.Cell death in the peripheral nervous system: potential rescue strategies.A Phase I safety study of hyperbaric oxygen therapy for amyotrophic lateral sclerosis.Emerging strategies for drug development in motor neuron disease.Antioxidants as treatment for neurodegenerative disorders.Antioxidative and steroid systems in neurological and psychiatric disorders.Genipin Derivatives Protect RGC-5 from Sodium Nitroprusside-Induced Nitrosative Stress.Redox proteomics in some age-related neurodegenerative disorders or models thereofOutcomes of physical therapy, speech pathology, and occupational therapy for people with motor neuron disease: a systematic review.Multifaceted role of nitric oxide in an in vitro mouse neuronal injury model: transcriptomic profiling defines the temporal recruitment of death signalling cascades.Protective effects of Debo on zinc-induced apoptosis of C6 glial cells via modulation of intracellular antioxidant, reduced glutathione.Symptomatic treatments for amyotrophic lateral sclerosis/motor neuron disease.Atorvastatin Protects NSC-34 Motor Neurons Against Oxidative Stress by Activating PI3K, ERK and Free Radical Scavenging.Paeonol attenuates H₂O₂-induced NF-κB-associated amyloid precursor protein expression.Cerebrospinal Fluid from Sporadic Amyotrophic Lateral Sclerosis Patients Induces Mitochondrial and Lysosomal Dysfunction.Development and characterisation of a glutamate-sensitive motor neurone cell line.Antioxidant Formulae, Shengmai San, and LingGuiZhuGanTang, Prevent MPTP Induced Brain Dysfunction and Oxidative Damage in MiceProtective activity of aromatic amines and imines against oxidative nerve cell death.Methionine oxidation inhibits fibrillation of human alpha-synuclein in vitro.Reduction of oxidative stress in amyotrophic lateral sclerosis following pramipexole treatment.Tat-protein disulfide-isomerase A3: a possible candidate for preventing ischemic damage in the spinal cord.A study of the purine derivative AIT-082 in G93A SOD1 transgenic mice.New Strategy That Delays Progression of Amyotrophic Lateral Sclerosis in G1H-G93A Transgenic Mice: Oral Administration of Xanthine Oxidoreductase Inhibitors That Are Not Substrates for the Purine Salvage Pathway.Biomarkers of PAH exposure and hematologic effects in subjects exposed to combustion emission during residential (and professional) cooking practices in Pakistan.Toxic effects of copper sulfate on the brains of term Hubbard broiler chicks: a stereological and biochemical study.The effect of Zn(2+) on Pelodiscus sinensis creatine kinase: unfolding and aggregation studies.Rapid rates of newly synthesized mitochondrial protein degradation are significantly affected by the generation of mitochondrial free radicals
P2860
Q24187671-5C63899F-CB2A-4D06-A900-4F5EA277E74DQ24240623-9AFD4A60-E470-48FB-B0B7-6BFC89C0CC5DQ24242160-34630351-8E0D-4482-80FF-8890D9E68D1FQ26782807-28BE0D61-8F98-4770-90A1-40AB0A11C59CQ26782894-3FC94269-AB49-4AA8-B50D-EA2BD0AD9A34Q28345018-B5E4ECE6-A14E-47CD-8058-9B9564C60129Q30865041-84A65C2C-580B-45A2-8CF9-BB20449B83E2Q31144652-DC013898-2F7A-4469-93D5-14C5D3C92902Q34352949-0E6F0191-7517-49E3-B94C-0C81431ACC43Q34529394-1CF76D59-6171-4219-A7BE-2B9FD1CF2C22Q34556331-03520415-B704-4DFF-9D6E-7DA9DDB41336Q34581485-E5B0ECCA-0BB7-4FA6-85AC-4287C5241367Q34974866-059B4584-4C50-4B5D-8A57-1C84890EF635Q36227621-630C6187-E70D-4E6E-930C-2E94AA25817EQ36512655-E8D688FE-A6DD-4A39-A17C-6E9F4E5F79D7Q36525171-FF504EA2-10A2-4932-98BE-BCA76D48956BQ36555304-2B2EE6D9-C9F5-4614-BDEB-4753E66412B6Q37295203-E2AB4309-205A-4779-9677-4465211480FAQ38523970-600D9909-1317-4A37-A372-F080430960AAQ38772250-69E69A7C-877E-4F6C-8FE1-B6ADDF89470DQ38921294-22A5C46C-E7E5-4C6F-896C-0F28C607CD92Q39634166-6ABC7688-F6B4-4000-8C58-9028D87B9DB4Q40233562-F00B2D28-2093-4C8C-B42E-7FC00F02A2EDQ40881505-CFC0C339-1F7D-4ACF-8CED-0275F87F34DCQ42155784-CC79B8D3-E54A-4BA8-9355-4934350474DDQ43840174-7E4D9EEF-99C7-4F25-8EE6-D91AD2DE00FCQ44026039-DA214C0E-EE19-455E-8BC5-8BE24F0F9C40Q44594676-E8B275B7-8782-459B-9725-FBCA472AF143Q46294178-16A23D12-C798-447C-A95C-EB4C9F63E402Q48402526-B6929D03-87A7-45BC-B225-9939C98ADDDBQ48942591-E475FB5C-2023-42C2-9804-19263AC9D99FQ50437314-A67FF7D8-8AA2-46C6-83FB-F53EDF4838F7Q50734326-BF96A47A-9E22-49D8-8067-268D3BDDA1BCQ54491195-D163A5ED-5250-4976-8932-89DCF3CA7B6DQ57655411-8C6912B2-36AE-4F49-B9FE-CCE38A6A57DE
P2860
description
im April 2006 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована у квітні 2006
@uk
name
Oxidative Stress and Motor Neurone Disease
@en
Oxidative Stress and Motor Neurone Disease
@nl
type
label
Oxidative Stress and Motor Neurone Disease
@en
Oxidative Stress and Motor Neurone Disease
@nl
prefLabel
Oxidative Stress and Motor Neurone Disease
@en
Oxidative Stress and Motor Neurone Disease
@nl
P2860
P1433
P1476
Oxidative Stress and Motor Neurone Disease
@en
P2093
Pamela J. Shaw
P2860
P304
P356
10.1111/J.1750-3639.1999.TB00217.X
P577
2006-04-05T00:00:00Z